Schistosomiasis

• FDA approval · 2023-12-19
  FDA Approved: BILTRICIDE — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

  FDA approved a supplemental application for Biltricide (praziquantel) to update the label with expanded indications for treating helminth in…

• EMA approval · 2023-12-15
  New treatment for young children with parasitic disease schistosomiasis

  EMA CHMP adopted a positive scientific opinion for Arpraziquantel to treat schistosomiasis in young children aged 3 months to 6 years.

• FDA approval · 2019-01-08
  FDA Approved: BILTRICIDE — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

  FDA approved a supplemental application for Biltricide (praziquantel) from Bayer HealthCare Pharmaceuticals Inc. This approval results in an…

• FDA approval · 2017-11-27
  FDA Approved: PRAZIQUANTEL — Original Application (Endo USA, Inc.)

  The FDA approved Endo USA, Inc.'s original application for praziquantel, enabling a generic version of the antihelminthic.

• FDA approval · 2014-11-20
  FDA Approved: BILTRICIDE — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

  FDA approved a supplemental application for Biltricide (praziquantel) from Bayer HealthCare Pharmaceuticals Inc., authorizing changes to the…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2014-02-25
  FDA Approved: BILTRICIDE — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

  FDA approved a supplemental application for Biltricide (praziquantel) from Bayer HealthCare Pharmaceuticals, authorizing changes to the prod…

• FDA approval · 2010-08-16
  FDA Approved: BILTRICIDE — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

  The FDA approved a supplemental application for Biltricide (praziquantel) filed by Bayer HealthCare Pharmaceuticals Inc., updating the produ…